• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION IMPLANTABLE NEUROSTIMULATOR; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION IMPLANTABLE NEUROSTIMULATOR; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE Back to Search Results
Model Number NEU_INS_STIMULATOR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Pain (1994); Therapeutic Response, Decreased (2271); Complaint, Ill-Defined (2331)
Event Date 07/11/2020
Event Type  Injury  
Manufacturer Narrative
Date of event: please note that this date is based off of the date that the article was accepted for publication as the event dates were not provided in the published literature.Concomitant medical products: product id: neu_ins_stimulator, lot#: unknown, product type: implantable neurostimulator.Product id: neu_ins_stimulator, lot#: unknown, product type: implantable neurostimulator.Product id: neu_ins_stimulator, lot#: unknown, product type: implantable neurostimulator.Product id: neu_ins_stimulator, lot#: unknown, product type: implantable neurostimulator.Product id: neu_ins_stimulator, lot#: unknown, product type: implantable neurostimulator.Product id: neu_ins_stimulator, lot#: unknown, product type: implantable neurostimulator.Product id: neu_ins_stimulator, serial/lot #: unknown.Product id: neu_ins_stimulator, serial/lot #: unknown.Product id: neu_ins_stimulator, serial/lot #: unknown.Product id: neu_ins_stimulator, serial/lot #: unknown.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Rubio-perez, i., saavedra, j., marijuan, j.L., pascual-miguelanez, i.Optimizing sacral neuromodulation for low anterior resection syndrome: learning from our experience.Colorectal dis.2020.Doi: 10.1111/codi.15261.Summary: the aim of this work was to review our institutional series of patients treated with sacral neuromodulation (snm) for low anterior resection syndrome (lars) and evaluate possible factors associated with therapeutic success.Method twenty-five patients were treated with snm for lars between 2008 and 2019.Snm was performed as per our institutional protocol.Patients were evaluated with wexner and lars scores before and after snm treatment.A visual analogue scale (1¿10) was used to evaluate overall patient satisfaction with snm.There were significant differences between the mean lars score values before (37.82) and after (29) snm therapy (p < 0.004).The mean wexner score was higher (16.24) before snm treatment than afterwards (11.13) (p < 0.004).There was a direct relationship between the height of anastomosis and lars score (p = 0.035): there were big changes in lars scoring (pre-/post-snm therapy) in patients with higher anastomoses, and vice versa.Patients who received radiotherapy scored lower in mean satisfaction (6.38) than patients without previous radiotherapy (8.22) (p = 0.008).There was an important positive association between wexner score and patient satisfaction (p = 0.001): relevant changes in wexner scoring after snm therapy were associated with high patient satisfaction, and vice versa.Our study showed a relationship between changes in wexner and lars scores before and after snm and overall patient satisfaction with snm therapy.These findings also suggest patients with previous radiotherapy may have worse results with snm (based on lower overall satisfaction), and that higher anastomoses have a greater impact on the post-snm lars score.Reported events: it was reported that one patient (4%) experienced an infection.One patient (4%) experienced a loss of effect and their device was explanted.One patient (4%) experienced pain and their device was explanted.One patient (4%) experienced an extrusion and underwent a revision.One patient (4%) experienced pain and underwent a revision.No specific device information provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE NEUROSTIMULATOR
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer Contact
david gustafson
7000 central avenue ne rcw215
minneapolis, MN 55432
7635149628
MDR Report Key10839233
MDR Text Key218515719
Report Number2182207-2020-01274
Device Sequence Number1
Product Code EZW
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
P080025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEU_INS_STIMULATOR
Device Catalogue NumberNEU_INS_STIMULATOR
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/23/2020
Initial Date FDA Received11/13/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-